MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Critical Care
Critical Care

Paracetamol Lowers Cerebral Temperature Modestly but Meaningfully in Febrile Brain‑Injured Patients: Results of the NEUROTHERM Randomized Pharmacodynamic Trial

MedXY Editorial TeamDec 9, 2025
critical carefeverparacetamol

Highlight

– A single intravenous dose of paracetamol reduced mean cerebral temperature (CT) by 0.6°C versus placebo over 6 hours in febrile brain‑injured patients (n = 99).

– Paracetamol maintained CT <38.5°C for a median 215 minutes vs. 0 minutes with placebo; however, ~30% of treated patients were nonresponders.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Navigating Uncertainty: The Future Impact of Artificial Intelligence in Critical Care through Ten Paradigms

Critical CareNov 5, 2026

Evaluating Cluster vs. Individual Randomization in Acute Care Trials: Insights from a Meta-Epidemiological Study

Critical CareNov 4, 2026

Global Disparities in Intensive Care Unit Resources and Organization: Insights from the ISOREA Survey

Critical CareOct 27, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story